Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|64|4|1121-1135

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.64, Iss.4, 2016-10, pp. : 1121-1135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generation of pediatric liver cancer patient–derived xenograft platforms for pediatric liver cancer: A critical stage in the development of anticancer treatments

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1017-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐derived xenografts for individualized care in advanced sarcoma

By  

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 2006-2015

John Wiley & Sons Inc

Access to resources Recommend Favorite

Establishment of primary patient‐derived xenografts of palliative TURP specimens to study castrate‐resistant prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 13, 2015-09 ,pp. : 1475-1483

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐derived organoid models help define personalized management of gastrointestinal cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 2, 2018-01 ,pp. : e48-e60

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comprehensively characterized large panel of head and neck cancer patient‐derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 12, 2015-06 ,pp. : 2940-2948

John Wiley & Sons Inc

Access to resources Recommend Favorite